MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Melanoma|Colonic Neoplasms|Breast Neoplasms
Interventions: DRUG: PD-0325901
Sponsor: Pfizer